Your browser is no longer supported. Please, upgrade your browser.
Settings
MRNA [NASD]
Moderna, Inc.
IndexS&P 500 P/E17.40 EPS (ttm)16.28 Insider Own1.90% Shs Outstand404.00M Perf Week-8.76%
Market Cap112.95B Forward P/E10.77 EPS next Y26.32 Insider Trans-14.91% Shs Float366.80M Perf Month15.82%
Income7.06B PEG1.04 EPS next Q6.86 Inst Own61.20% Short Float3.97% Perf Quarter-37.84%
Sales11.83B P/S9.55 EPS this Y-26.10% Inst Trans5.86% Short Ratio1.06 Perf Half Y30.60%
Book/sh25.06 P/B11.31 EPS next Y2.18% ROA49.50% Target Price304.92 Perf Year66.84%
Cash/sh22.35 P/C12.68 EPS next 5Y16.80% ROE121.60% 52W Range102.66 - 497.49 Perf YTD171.27%
Dividend- P/FCF9.92 EPS past 5Y- ROI-28.40% 52W High-43.03% Beta-
Dividend %- Quick Ratio1.30 Sales past 5Y- Gross Margin85.90% 52W Low176.06% ATR27.49
Employees1300 Current Ratio1.30 Sales Q/Q6398.50% Oper. Margin64.30% RSI (14)47.32 Volatility9.02% 6.87%
OptionableYes Debt/Eq0.05 EPS Q/Q- Profit Margin59.70% Rel Volume0.52 Prev Close282.35
ShortableYes LT Debt/Eq0.02 EarningsNov 04 BMO Payout0.00% Avg Volume13.72M Price283.40
Recom2.70 SMA203.07% SMA50-7.69% SMA2007.63% Volume7,086,707 Change0.37%
Dec-07-21Initiated Cowen Market Perform
Nov-09-21Initiated Wolfe Research Outperform $304
Oct-22-21Initiated Deutsche Bank Sell $250
Oct-15-21Upgrade Piper Sandler Neutral → Overweight $445
Aug-06-21Downgrade Piper Sandler Overweight → Neutral $246 → $445
Aug-06-21Downgrade Oppenheimer Outperform → Perform
Jul-15-21Reiterated Jefferies Hold $170 → $250
Feb-01-21Downgrade BofA Securities Neutral → Underperform
Dec-16-20Downgrade Morgan Stanley Overweight → Equal-Weight $150
Dec-16-20Downgrade Jefferies Buy → Hold $90 → $150
Dec-09-20Downgrade Needham Buy → Hold
Nov-23-20Initiated Wells Fargo Equal Weight $92
Nov-17-20Downgrade BMO Capital Markets Outperform → Market Perform $109
Sep-08-20Downgrade SVB Leerink Mkt Perform → Underperform $58 → $41
Jul-23-20Initiated SVB Leerink Mkt Perform
Jul-20-20Downgrade JP Morgan Overweight → Neutral $89
Jul-13-20Initiated Jefferies Buy $90
Jun-30-20Initiated Argus Buy $80
Jun-08-20Initiated Barclays Overweight $68
Apr-30-20Initiated BMO Capital Markets Outperform $83
Dec-08-21 07:38PM  
07:38PM  
04:38PM  
04:38PM  
03:43PM  
01:16PM  
10:30AM  
09:46AM  
09:43AM  
09:29AM  
09:20AM  
09:18AM  
07:45AM  
06:43AM  
Dec-07-21 09:07PM  
04:41PM  
04:38PM  
01:12PM  
12:26PM  
10:30AM  
10:29AM  
08:08AM  
Dec-06-21 06:50PM  
06:30PM  
05:46PM  
04:49PM  
04:19PM  
04:10PM  
03:55PM  
02:45PM  
01:54PM  
11:43AM  
11:41AM  
11:30AM  
11:20AM  
09:38AM  
08:04AM  
08:00AM  
05:57AM  
Dec-05-21 03:40PM  
01:26PM  
06:55AM  
06:00AM  
Dec-04-21 04:16PM  
06:55AM  
06:30AM  
05:57AM  
05:15AM  
Dec-03-21 07:06PM  
07:00PM  
04:15PM  
04:13PM  
03:22PM  
02:48PM  
02:38PM  
02:35PM  
12:34PM  
11:55AM  
11:45AM  
09:20AM  
07:31AM  
06:58AM  
04:56AM  
Dec-02-21 06:30PM  
05:29PM  
04:00PM  
02:40PM  
02:23PM  
02:19PM  
01:42PM  
01:13PM  
11:39AM  
11:31AM  
11:11AM  
10:54AM  
10:43AM  
09:53AM  
09:08AM  
06:40AM  
06:15AM  
06:00AM  
Dec-01-21 09:28PM  
06:22PM  
05:44PM  
05:30PM  
04:11PM  
03:33PM  
02:51PM  
02:43PM  
02:36PM  
01:54PM  
12:20PM  
11:58AM  
11:37AM  
09:49AM  
08:21AM  
08:13AM  
07:22AM  
06:40AM  
06:03AM  
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted and cell surface therapeutics, and systemic intracellular therapeutics. The company has strategic alliances with AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, the Biomedical Advanced Research and Development Authority, the Defense Advanced Research Projects Agency, the National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmaceuticos Rovi, S.A., Recipharm, and Lonza Group for fill-finish manufacturing of its COVID-19 vaccine candidate, as well as Aldevron, LLC for supporting COVID-19 vaccine and additional programs in company's clinical development pipeline. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andres JuanSee remarksDec 06Option Exercise13.5515,000203,25015,000Dec 07 04:07 PM
Andres JuanSee remarksDec 06Sale280.6015,0004,209,0000Dec 07 04:07 PM
Hoge StephenPresidentDec 03Option Exercise0.9910,0009,9001,619,597Dec 06 04:26 PM
Andres JuanSee remarksDec 03Option Exercise12.215,00061,0505,000Dec 07 04:07 PM
Hoge StephenPresidentDec 03Sale318.4010,0003,184,0001,609,597Dec 06 04:26 PM
Andres JuanSee remarksDec 03Sale318.405,0001,592,0000Dec 07 04:07 PM
Hoge StephenPresidentDec 02Option Exercise0.9910,0009,9001,619,597Dec 06 04:26 PM
Hoge StephenPresidentDec 02Sale301.2910,0003,012,9001,609,597Dec 06 04:26 PM
Bancel StephaneChief Executive OfficerDec 02Sale301.2910,0003,012,9007,124,880Dec 03 04:59 PM
Andres JuanSee remarksDec 01Option Exercise12.215,00061,0505,000Dec 03 05:04 PM
Bancel StephaneChief Executive OfficerDec 01Sale329.919,0002,969,1905,944,535Dec 03 04:59 PM
Andres JuanSee remarksDec 01Sale329.915,0001,649,5500Dec 03 05:04 PM
Andres JuanSee remarksNov 29Option Exercise12.215,00061,0505,000Nov 30 04:09 PM
Andres JuanSee remarksNov 29Sale370.385,0001,851,9000Nov 30 04:09 PM
Andres JuanSee remarksNov 26Option Exercise12.215,00061,0505,000Nov 30 04:09 PM
Andres JuanSee remarksNov 26Sale319.625,0001,598,1000Nov 30 04:09 PM
Bancel StephaneChief Executive OfficerNov 26Sale319.6210,0003,196,2007,134,880Nov 30 04:12 PM
Andres JuanSee remarksNov 24Option Exercise12.215,00061,0505,000Nov 26 02:08 PM
Andres JuanSee remarksNov 24Sale273.015,0001,365,0500Nov 26 02:08 PM
Bancel StephaneChief Executive OfficerNov 24Sale273.019,0002,457,0905,940,868Nov 26 01:59 PM
Hoge StephenPresidentNov 23Option Exercise4.2915,00064,4001,624,597Nov 26 02:20 PM
Hoge StephenPresidentNov 23Sale275.5215,0004,132,7721,609,597Nov 26 02:20 PM
Andres JuanSee remarksNov 22Option Exercise13.5515,000203,25015,000Nov 23 06:16 PM
Andres JuanSee remarksNov 22Sale268.1815,0004,022,7000Nov 23 06:16 PM
Andres JuanSee remarksNov 19Option Exercise12.215,00061,0505,000Nov 23 06:16 PM
Andres JuanSee remarksNov 19Sale265.715,0001,328,5500Nov 23 06:16 PM
Bancel StephaneChief Executive OfficerNov 18Sale245.8910,0002,458,9007,144,880Nov 19 04:09 PM
Andres JuanSee remarksNov 17Option Exercise12.215,00061,0505,000Nov 19 04:15 PM
Bancel StephaneChief Executive OfficerNov 17Sale234.579,0002,111,1305,953,868Nov 19 04:09 PM
Andres JuanSee remarksNov 17Sale234.575,0001,172,8500Nov 19 04:15 PM
Andres JuanSee remarksNov 15Option Exercise12.215,00061,0505,000Nov 16 04:23 PM
Hoge StephenPresidentNov 15Option Exercise4.2915,00064,4001,624,597Nov 16 04:25 PM
Andres JuanSee remarksNov 15Sale231.015,0001,155,0500Nov 16 04:23 PM
Hoge StephenPresidentNov 15Sale231.0115,0003,465,1501,609,597Nov 16 04:25 PM
Andres JuanSee remarksNov 12Option Exercise12.215,00061,0505,000Nov 16 04:23 PM
Hoge StephenPresidentNov 12Option Exercise10.905,00054,5001,614,597Nov 16 04:25 PM
Andres JuanSee remarksNov 12Sale225.865,0001,129,3000Nov 16 04:23 PM
Hoge StephenPresidentNov 12Sale225.865,0001,129,3001,609,597Nov 16 04:25 PM
Bancel StephaneChief Executive OfficerNov 11Sale227.6710,0002,276,7007,154,880Nov 12 04:07 PM
Andres JuanSee remarksNov 10Option Exercise12.215,00061,0505,000Nov 12 04:16 PM
Bancel StephaneChief Executive OfficerNov 10Sale230.009,0002,070,0005,996,868Nov 12 04:07 PM
Andres JuanSee remarksNov 10Sale230.005,0001,150,0000Nov 12 04:16 PM
Andres JuanSee remarksNov 08Option Exercise13.5515,000203,25015,000Nov 09 04:36 PM
Andres JuanSee remarksNov 08Sale233.1315,0003,496,9500Nov 09 04:36 PM
Andres JuanSee remarksNov 05Option Exercise12.215,00061,0505,000Nov 09 04:36 PM
Andres JuanSee remarksNov 05Sale240.005,0001,200,0000Nov 09 04:36 PM
Bancel StephaneChief Executive OfficerNov 04Sale295.5010,0002,955,0007,164,880Nov 05 05:04 PM
Hoge StephenPresidentNov 03Option Exercise0.9910,0009,9001,619,597Nov 04 04:43 PM
Andres JuanSee remarksNov 03Option Exercise12.215,00061,0505,000Nov 05 05:09 PM
Hoge StephenPresidentNov 03Sale350.0010,0003,500,0001,609,597Nov 04 04:43 PM
Bancel StephaneChief Executive OfficerNov 03Sale350.009,0003,150,0006,009,868Nov 05 05:04 PM
Andres JuanSee remarksNov 03Sale350.005,0001,750,0000Nov 05 05:09 PM
Hoge StephenPresidentNov 02Option Exercise0.9910,0009,9001,619,597Nov 04 04:43 PM
Hoge StephenPresidentNov 02Sale338.5410,0003,385,4001,609,597Nov 04 04:43 PM
Andres JuanSee remarksNov 01Option Exercise12.215,00061,0505,000Nov 02 04:16 PM
Andres JuanSee remarksNov 01Sale335.005,0001,675,0000Nov 02 04:16 PM
Andres JuanSee remarksOct 29Option Exercise12.215,00061,0505,000Nov 02 04:16 PM
Andres JuanSee remarksOct 29Sale344.495,0001,722,4500Nov 02 04:16 PM
Bancel StephaneChief Executive OfficerOct 28Sale343.7410,0003,437,4007,174,880Oct 29 04:36 PM
Andres JuanSee remarksOct 27Option Exercise12.215,00061,0505,000Oct 29 04:32 PM
Andres JuanSee remarksOct 27Sale344.255,0001,721,2500Oct 29 04:32 PM
Bancel StephaneChief Executive OfficerOct 27Sale344.259,0003,098,2506,022,868Oct 29 04:36 PM
Hoge StephenPresidentOct 25Option Exercise5.9520,000118,9001,629,597Oct 26 06:00 PM
Andres JuanSee remarksOct 25Option Exercise12.2315,000183,50815,000Oct 26 05:13 PM
Hoge StephenPresidentOct 25Sale331.8020,0006,636,0971,609,597Oct 26 06:00 PM
Andres JuanSee remarksOct 25Sale327.3615,0004,910,4000Oct 26 05:13 PM
Andres JuanSee remarksOct 22Option Exercise12.215,00061,0505,000Oct 26 05:13 PM
Andres JuanSee remarksOct 22Sale333.005,0001,665,0000Oct 26 05:13 PM
Bancel StephaneChief Executive OfficerOct 21Sale337.0010,0003,370,0007,184,880Oct 22 05:23 PM
Andres JuanSee remarksOct 20Option Exercise12.215,00061,0505,000Oct 22 05:39 PM
Bancel StephaneChief Executive OfficerOct 20Sale333.909,0003,005,1006,035,868Oct 22 05:23 PM
Andres JuanSee remarksOct 20Sale333.905,0001,669,5000Oct 22 05:39 PM
Andres JuanSee remarksOct 18Option Exercise12.215,00061,0505,000Oct 19 04:11 PM
Andres JuanSee remarksOct 18Sale322.265,0001,611,3000Oct 19 04:11 PM
Andres JuanSee remarksOct 15Option Exercise12.215,00061,0505,000Oct 19 04:11 PM
Andres JuanSee remarksOct 15Sale341.255,0001,706,2500Oct 19 04:11 PM
Bancel StephaneChief Executive OfficerOct 14Sale329.0010,0003,290,0007,194,880Oct 15 04:05 PM
Hoge StephenPresidentOct 13Option Exercise4.2915,00064,4001,624,597Oct 14 04:10 PM
Andres JuanSee remarksOct 13Option Exercise12.215,00061,0505,000Oct 14 04:21 PM
SAGAN PAULDirectorOct 13Sale314.902,250708,52514,951Oct 15 04:03 PM
Bancel StephaneChief Executive OfficerOct 13Sale314.909,0002,834,1006,048,868Oct 15 04:05 PM
Hoge StephenPresidentOct 13Sale314.9015,0004,723,5001,609,597Oct 14 04:10 PM
Andres JuanSee remarksOct 13Sale314.905,0001,574,5000Oct 14 04:21 PM
Hoge StephenPresidentOct 12Option Exercise10.905,00054,5001,614,597Oct 14 04:10 PM
Hoge StephenPresidentOct 12Sale313.225,0001,566,1001,609,597Oct 14 04:10 PM
Andres JuanSee remarksOct 11Option Exercise12.2115,000183,15015,000Oct 12 04:16 PM
Andres JuanSee remarksOct 11Sale300.0015,0004,500,0000Oct 12 04:16 PM
Andres JuanSee remarksOct 08Option Exercise12.215,00061,0505,000Oct 12 04:16 PM
Andres JuanSee remarksOct 08Sale310.445,0001,552,2000Oct 12 04:16 PM
Bancel StephaneChief Executive OfficerOct 07Sale295.0010,0002,950,0007,204,880Oct 08 04:14 PM
Andres JuanSee remarksOct 06Option Exercise12.215,00061,0505,000Oct 08 04:18 PM
Bancel StephaneChief Executive OfficerOct 06Sale318.239,0002,864,0706,061,868Oct 08 04:14 PM
Andres JuanSee remarksOct 06Sale318.235,0001,591,1500Oct 08 04:18 PM
Hoge StephenPresidentOct 04Option Exercise0.9920,00019,8001,629,597Oct 06 04:09 PM
Andres JuanSee remarksOct 04Option Exercise12.215,00061,0505,000Oct 05 04:12 PM
Hoge StephenPresidentOct 04Sale307.5420,0006,150,8001,609,597Oct 06 04:09 PM
Andres JuanSee remarksOct 04Sale307.545,0001,537,7000Oct 05 04:12 PM
Andres JuanSee remarksOct 01Option Exercise12.215,00061,0505,000Oct 05 04:12 PM
Andres JuanSee remarksOct 01Sale359.005,0001,795,0000Oct 05 04:12 PM
Bancel StephaneChief Executive OfficerSep 30Sale381.8210,0003,818,2007,214,880Oct 01 08:50 AM